Categories AlphaGraphs, Earnings, Health Care

PFE Earnings: All you need to know about Pfizer’s Q2 2023 earnings results

Pfizer Inc. (NYSE: PFE) reported second quarter 2023 earnings results today.

Revenues decreased 54% year-over-year to $12.7 billion.

Reported net income declined 77% to $2.3 billion, or $0.41 per share, compared to last year. Adjusted EPS fell 67% to $0.67.

While earnings beat expectations, revenue fell short of estimates.

For the full year of 2023, revenues are expected to range between $67-70 billion while adjusted EPS is estimated to range between $3.25-3.45.

The stock dropped 1% in premarket hours on Tuesday following the report.

Prior performance

Most Popular

Nike (NKE) looks set to beat hurdles and build a brighter future

Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business

Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company

Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as

Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor

Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications

Add Comment
Viewing Highlight